Colon cancer is on the rise in young people – so should the under-55s pay for a colonoscopy?
The NHS doesn’t offer bowel screening until we’re 50. Yet with cancer rates rising, it may be worth forking out for a private ...
Biodexa Pharmaceuticals PLC: Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer
Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (Nasdaq: BDRX), a clinical ...
Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer
Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ( ...
Seeking Alpha22d
Recursion Pharmaceuticals: Betting Big On AI
small-molecule inhibitor of the mitogen-activated protein kinase 1 and 2 proteins/pathways that is being investigated in the treatment of familial adenomatous polyposis (FAP), a rare tumor ...
ascopubs.org27d
Landscape of Multilocus Inherited Neoplasia Allele Syndrome in Mexican Population
253). Patients with MINAS were diagnosed with hereditary breast and ovarian cancer (HBOC) syndrome in 22 (95.65%) cases and with familial adenomatous polyposis (FAP) in one (4.34%) case. The most ...
Pharmaceutical Technology29d
ALM-412 by Almirall for Familial Adenomatous Polyposis: Likelihood of Approval
ALM-412 is under clinical development by Almirall and currently in Phase I for Familial Adenomatous Polyposis. According to GlobalData, Phase I drugs for Familial Adenomatous Polyposis have a 78% ...